Captrust Financial Advisors Haemonetics Corp Transaction History

Captrust Financial Advisors

$43.1 Billion
Q2 2025

A detailed history of Captrust Financial Advisors transactions in Haemonetics Corp stock. As of the latest transaction made, Captrust Financial Advisors holds 11,021 shares of HAE stock, worth $554,025. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,021

Previous 4,361 152.72%

Holding current value

$554,025

Previous $277,000 196.75%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$56.04 - $74.77 $373,226 - $497,968	6,660 Added 152.72%	11,021 $822,000
Q1 2025 May 14, 2025	SELL	$59.34 - $80.05 $30,322 - $40,905	-511 Reduced 10.49%	4,361 $277,000
Q4 2024 Feb 14, 2025	BUY	$71.16 - $93.38 $44,403 - $58,269	624 Added 14.69%	4,872 $380,000
Q3 2024 Nov 14, 2024	BUY	$72.45 - $91.58 $71,145 - $89,931	982 Added 30.07%	4,248 $341,000
Q2 2024 Aug 14, 2024	BUY	$81.24 - $97.37 $5,036 - $6,036	62 Added 1.94%	3,266 $270,000
Q1 2024 May 15, 2024	SELL	$71.24 - $85.35 $238,867 - $286,178	-3,353 Reduced 51.14%	3,204 $273,000
Q4 2023 Feb 14, 2024	SELL	$80.59 - $92.61 $343,716 - $394,981	-4,265 Reduced 39.41%	6,557 $560,000
Q3 2023 Nov 14, 2023	BUY	$82.56 - $93.49 $153,974 - $174,358	1,865 Added 20.82%	10,822 $969,000
Q2 2023 Aug 14, 2023	BUY	$80.84 - $89.45 $724,083 - $801,203	8,957 New	8,957 $762,000
Q2 2022 Aug 23, 2022	SELL	$49.27 - $66.08 $5,370 - $7,202	-109 Reduced 4.62%	2,250 $147,000
Q2 2022 Aug 16, 2022	BUY	$49.27 - $66.08 $1,182 - $1,585	24 Added 1.03%	2,359 $154,000
Q1 2022 May 16, 2022	BUY	$43.77 - $63.22 $25,605 - $36,983	585 Added 33.43%	2,335 $148,000
Q4 2021 Feb 14, 2022	SELL	$49.55 - $74.59 $20,067 - $30,208	-405 Reduced 18.79%	1,750 $93,000
Q3 2021 Nov 16, 2021	BUY	$57.6 - $70.59 $6,048 - $7,411	105 Added 5.12%	2,155 $152,000
Q2 2021 Aug 16, 2021	BUY	$51.81 - $118.56 $2,072 - $4,742	40 Added 1.99%	2,050 $137,000
Q1 2021 May 17, 2021	BUY	$111.01 - $139.48 $208,143 - $261,524	1,875 Added 1388.89%	2,010 $223,000
Q3 2020 Nov 17, 2020	BUY	$75.65 - $93.58 $8,321 - $10,293	110 Added 440.0%	135 $12,000
Q2 2020 Aug 14, 2020	BUY	$84.96 - $118.91 $2,124 - $2,972	25 New	25 $2,000
Q4 2019 Feb 14, 2020	SELL	$114.37 - $129.46 $2,859 - $3,236	-25 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$81.74 - $120.34 $2,043 - $3,008	25 New	25 $3,000

Others Institutions Holding HAE

# of Institutions

331

Shares Held

53.3M

Call Options Held

304K

Put Options Held

77.8K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $2.58B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Haemonetics Corp Transaction History